Although cancer mortality in the United States (US) has decreased by 28% during the past three decades, with more than 2.6 million deaths being averted during this period, cancer still continues to be the second cause of death. Nearly 1.8 million new cancer cases and over 600,000 deaths are predicted for 2019. While we have witnessed significant decrease in lung, colorectal, prostate and breast cancer, the incidence of melanoma, hepatic, thyroid, uterine, and pancreatic cancers has increased. It is also worth noting that more than two-thirds of these cancers are preventable due to modifiable risk factors such as obesity, alcohol consumption, smoking, and hepatitis B and C viruses.
Significant differences in cancer incidence and mortality rates are due to socioeconomic inequities. In recent years socioeconomic difference in the US has been increasingly recognized as a major contributing factor to disease in general, and cancer specifically. Following advances in treatment, the US has witnessed an increase in cancer survivorship. Recent estimates show that there are more than 15 million cancer survivors and this is set to rise to more than 20 million in the next decades. Cancer survivorship is associated with a number of physical, social, psychological, and existential stressors in addition to the cost of diagnosis and treatment. Hence, there is a growing need for research in high-quality patient care.
This Research Topic welcomes Original Research articles, Reviews, Mini-Reviews, Opinion and Perspective articles focusing on, but not limited to:
1) Understanding, preventing, and managing problems related to cancer survivorship;
2) Ways to decrease the economic burden and improve the quality of care, longevity, and quality of life in the US population.
Although cancer mortality in the United States (US) has decreased by 28% during the past three decades, with more than 2.6 million deaths being averted during this period, cancer still continues to be the second cause of death. Nearly 1.8 million new cancer cases and over 600,000 deaths are predicted for 2019. While we have witnessed significant decrease in lung, colorectal, prostate and breast cancer, the incidence of melanoma, hepatic, thyroid, uterine, and pancreatic cancers has increased. It is also worth noting that more than two-thirds of these cancers are preventable due to modifiable risk factors such as obesity, alcohol consumption, smoking, and hepatitis B and C viruses.
Significant differences in cancer incidence and mortality rates are due to socioeconomic inequities. In recent years socioeconomic difference in the US has been increasingly recognized as a major contributing factor to disease in general, and cancer specifically. Following advances in treatment, the US has witnessed an increase in cancer survivorship. Recent estimates show that there are more than 15 million cancer survivors and this is set to rise to more than 20 million in the next decades. Cancer survivorship is associated with a number of physical, social, psychological, and existential stressors in addition to the cost of diagnosis and treatment. Hence, there is a growing need for research in high-quality patient care.
This Research Topic welcomes Original Research articles, Reviews, Mini-Reviews, Opinion and Perspective articles focusing on, but not limited to:
1) Understanding, preventing, and managing problems related to cancer survivorship;
2) Ways to decrease the economic burden and improve the quality of care, longevity, and quality of life in the US population.
